148
•
Fernández-Veledo S (2010) Obesidad, inflamación y resistencia a la insulina
SEBBM divulgación
•
Ishibashi J, Seale P. (2010) Medicine. Beige can be slimming. Science. 328, 1113-
1114.
•
Lorenzo M y Benito M (2010) From insulin action to hormonal resistance. Old to
recent molecular mechanisms. En: Type 2Diabetes Mellitus. Eds Serrano-Rios, M, Fuentes
Gutierrez JA. Elsevier pp 105-130.
•
Maury,E, Brichard,SM (2010): Adipokine dysregulation, adipose tissue
inflammation and metabolic syndrome. Mol Cell Endocrinol 314, 1-16.
•
Mooradian AD (2009). Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract
Endocrinol Metab. 5, 150-159.
•
Obesidad y sobrepeso. Nota descriptiva N°311. Oreganización Mundial de la Salud.
Marzo de 2011
•
Phillips LK y Prins JB (2008) The link between abdominal obesity and the
metabolic syndrome. Current Hypertension Reports, . 10, 156–164
•
Puigserver P, Wu Z, Park CW, Graves R, Wright M and Spiegelman BM (1998): A
cold- inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell.
92:829–839.
•
Reaven GM (1995) Pathophysiology of insulin resistance in human disease.
Physiol Rev 75, 473–486.
•
Reaven GM (1998) Role of insulin resistance in human disease. Diabetes. 37, p.
1595–1607.
•
Serrano-Rios M (2011) Obesity and type 2 diabetes mellitus. The reciprocal impact.
En: Obesity (eds Serrano-Rios, Ordovas JM y Fuentes-Gutierrez JA. Elsevier pp 215-231
•
Shirai K (2004) Obesity as the core of the metabolic syndrome and the management
of coronary heart disease. Curr Med Res Opin 20, 295–304,
•
Shoelson SE, Lee J, Goldfine AB (2006). Inflammation and insulin resistance. J
Clin Invest 116, 1793-801.
